BioCryst公司的贝罗司他胶囊最新价格

On December 3, 2020, BioCryst announced that its once-daily oral Orladeyo was approved by the US FDA for the prevention of hereditary angioedema (HAE) attacks in children and adults aged 12 years and older. Berostat capsule Orladeyo is the first targeted oral therapy approved to prevent the onset of hereditary angioedema HAE. The approval of Orladeyo will bring significant progress in the treatment of patients with hereditary angioedema HAE and will help reduce the treatment burden on patients.

BioCryst Corporation is a biotechnology company. BioCryst designs, optimizes and develops small molecule drugs that block enzymes involved in disease pathogenesis. The company focuses on treating rare diseases. BioCryst uses X-ray scattering technology, molecular structure computer simulations and chemical techniques to focus on the three-dimensional molecular structure and active site characteristics of enzymes that control cell biology.

The latest price of BioCryst's berosstat capsules: If patients want to know the specific price information of berosstat capsules Orladeyo, or if they want to purchase the drug with a high cost-effectiveness overseas, they can consult with domestic reliable overseas medical service companies (such as Yibenlv).

Recommended dosage of Orladeyo: take one capsule (150 mg) once daily with food. Patients should not increase or decrease the dosage of the drug without authorization during treatment with Orladeyo. Increasing the dosage of the drug will not make the condition improve quickly, but will lead to adverse reactions. Therefore, patients should strictly follow the doctor's diagnosis and treatment recommendations and should not use medication without authorization. Berostat capsules Orladeyo should not be used to treat acute attacks of hereditary angioedema (HAE).

The above is the introduction about Orladeyo, I hope it can help everyone.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.